ROYALTY PHARMA PLC- CL A (RPRX) Stock Income Statement
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.26B | 2.26B | 2.35B | 2.24B | 2.29B | |||
| Minority Interest Expense | -675.97M | -471.83M | -565.25M | -187.20M | -621.50M | |||
| Operating Expenses | 363.44M | 971.13M | 862.40M | 1.31B | 858.70M | |||
| Research and Development | 52.00M | 2.00M | 52.00M | 177.10M | 200.10M | |||
| Selling, General, and Administrative Expenses | 289.72M | 236.67M | 249.75M | 227.30M | 182.80M | |||
| Operating Income | 1.90B | 1.29B | 1.49B | 922.90M | 1.43B | |||
| Interest Income/Expense | -130.98M | 39.90M | 229.68M | -62.20M | -183.80M | |||
| Other Income/Expense | -905.00K | -1.53M | -21.74M | -14.80M | -5.70M | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -615.80M | 0.00 | |||
| Income Before Taxes | 1.77B | 1.33B | 1.70B | 230.10M | 1.24B | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | 1.09B | 858.98M | 1.13B | 42.80M | 619.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.84 | 1.44 | 1.88 | 0.10 | 1.49 | |||
| Non GAAP EPS | 3.77 | 4.10 | 4.38 | 3.67 | 2.23 | |||
| Statistics | ||||||||
| Profit Margin | 48.26% | 37.95% | 48.20% | 1.91% | 27.07% | |||
| Operating Profit Margin | 83.95% | 57.10% | 63.37% | 41.25% | 62.49% | |||
All data in USD